This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

A Second View: Discussing the risks of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide

Ticker(s): NVO

Who's the expert?

Institution: Woolfson Eye Institute

  • Ophthalmologist concentrated on cataract surgery, as well as other eye problems at the Woolfson Eye Institute.
  • Currently manages 30 presbyopia patients monthly and is able to discuss the results from the Phase 2 INSIGHT trial of LNZ100 AND LNZ101 to treat presbyopia.
  • Experienced in cataract surgery including a procedure known as “minimally invasive glaucoma surgery.

Interview Goal
.

Do you want answers to these questions?

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.